Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:39 AM
Ignite Modification Date:
2025-12-25 @ 2:39 AM
NCT ID:
NCT02103634
Eligibility Criteria:
Inclusion Criteria:
* Referred to University Hospitals Cleveland Medical Center Nuclear Medicine for methylene diphosphonate (MDP) Bone Scintigraphy
* Must understand and voluntarily sign an Informed consent form after the contents have been fully explained to them.
* Patients must have no contra-indications to PET/CT or MRI (Patients will NOT be receiving either CT or MRI contrast and thus, those contraindications are not exclusionary).
Exclusion Criteria:
* Patients who cannot tolerate imaging up to 120 minutes of total imaging (breaks of several minutes between imaging will be available)
* Pregnant or breast feeding women.
* Healthy volunteers
* Inability to comply with instructions
* MRI contraindications Include:
* Patients with ferromagnetic or otherwise non-MRI compatible aneurysm clips
* Patients with implanted pacemaker or implanted defibrillator device
* Patients with contraindications for MRI due to embedded foreign metallic objects. Bullets, shrapnel, metalwork fragments, or other metallic material adds unnecessary risk to the patient
* Implanted medical device not described above that is not MRI-compatible
* Known history of claustrophobia
* Contrast contraindications not included since patients will not be receiving MRI or CT contrast as part of this study
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02103634
Study Brief:
Protocol Section:
NCT02103634